Group 1 - On January 26, Dongxing Medical experienced a decline of 0.42% with a transaction volume of 43.62 million yuan [1] - The financing data on January 26 shows that Dongxing Medical had a financing purchase amount of 2.91 million yuan and a financing repayment of 10.15 million yuan, resulting in a net financing buy of -7.24 million yuan [1] - As of January 26, the total balance of margin trading for Dongxing Medical was 98.52 million yuan, with the financing balance accounting for 4.99% of the circulating market value, indicating a high level compared to the past year [1] Group 2 - As of January 20, the number of shareholders for Dongxing Medical was 8,993, a decrease of 3.31% from the previous period, while the average circulating shares per person increased by 3.42% to 7,579 shares [2] - For the period from January to September 2025, Dongxing Medical reported an operating income of 284 million yuan, a year-on-year decrease of 10.21%, and a net profit attributable to the parent company of -53.20 million yuan, a year-on-year decrease of 181.13% [2] Group 3 - Since its A-share listing, Dongxing Medical has distributed a total of 169 million yuan in dividends [3]
东星医疗1月26日获融资买入291.26万元，融资余额9837.22万元